Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Advanced Composites
LeftNav
Aerospace
LeftNav
Amorphous Metal Structures
LeftNav
Analysis and Simulation
LeftNav
Asbestos and Substitutes
LeftNav
Associations, Research Organisations and Universities
LeftNav
Automation Equipment
LeftNav
Automotive
LeftNav
Biomaterials
LeftNav
Building Materials
LeftNav
Bulk Handling and Storage
LeftNav
CFCs and Substitutes
LeftNav
Company
LeftNav
Components
LeftNav
Consultancy
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
 
News

Researcher eyeing tobacco for factory of biopharmaceuticals

Virginia Polytechnic Institute And State University : 13 August, 2004  (Technical Article)
The economics of producing biopharmaceuticals from transgenic plants such as tobacco is still a roadblock to producing large quantities of urgently needed medicines, especially for people in underdeveloped nations.
The economics of producing biopharmaceuticals from transgenic plants such as tobacco is still a roadblock to producing large quantities of urgently needed medicines, especially for people in underdeveloped nations.

Chenming 'Mike' Zhang is testing a variety of ways to economically recover recombinant proteins from transgenic tobacco using different protein separation techniques.

Zhang, an assistant professor in the Department of Biological Systems Engineering (BSE) in the College of Engineering and the College of Agriculture and Life Sciences at Virginia Tech, is working with a team of three Ph.D. students to develop transgenic tobacco plants able to express recombinant proteins economically. Recombinant proteins are potential therapeutic agents for treating human and animal diseases and creating new vaccines. Plant-made vaccines are especially beneficial because plants are free of human diseases, reducing the cost to screen for viruses and bacterial toxins.

'Recombinant protein production from transgenic plants is challenging, not just from the molecular biology aspect to have high expression plant lines, but also from the engineering aspect to recover and purify the proteins economically -- the importance of which cannot be overlooked,' Zhang said.

Recombinant proteins are proteins expressed by a host other than their native hosts. For example, if the gene for human growth hormone is INSERTed into the genetic code of yeast (gene recombination), then the corresponding protein expressed in the yeast is called recombinant human growth hormone.

Zhangís research starts with introducing the genes of interest into tobacco plants and then developing economical processes for recovering and purifying the expressed proteins. Relaxin, one of the proteins his team is studying, could potentially benefit patients with asthma, hay fever, and even cardiovascular disease.

Because most recombinant proteins are for therapeutic uses, they need to be highly purified to be safe for human use. Thus, once a protein is expressed, whether by transgenic tobacco or bacteria, the protein first needs to be recovered into liquid solutions before purification.

'Because of the high purity required, the purification is rigorous and not surprisingly, very expensive. Therefore, development of more economical techniques for protein purification is always an engineering challenge in order to lower the cost of therapeutic proteins or biopharmaceuticals,' Zhang said.

Zhang uses tobacco in his research because it is a non-food crop and is well suited as a 'factory' for recombinant protein production. The leafy green tobacco plant is relatively easy to alter genetically and produces thousands of seeds and a great deal of biomass. As a non-food crop, genetically manipulated tobacco will not pose a safety threat to products consumed by humans. 'Since tobacco is neither a food nor a feed-crop, transgenic tobacco will not enter our food,' Zhang said.

The research is funded by Jeffress Memorial Trust and the Tobacco Initiative.

Zhang is the director of both the Protein Separation Laboratory and the Unit Operations Laboratory at Virginia Tech. The Protein Separation Laboratory supports research in protein expression and purification process development from transgenic plants and other expression systems. The Unit Operations Laboratory supports a course by the same name taught by Zhang in biological systems engineering. He also is affiliated with the Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences.

The College of Engineering Deanís Award for Outstanding Assistant Professor was presented to Zhang in 2004. His nomination was based on his extraordinary level of activities and accomplishments in curriculum development and teaching, development of a viable research program, and his cooperative efforts with colleagues at Virginia Tech and around the nation.

Before coming to Virginia Tech in 2001, Zhang was a research and development scientist for two years at Covance Biotechnology Services (now Diosynth RTP) in Cary, N.C.

Zhang received his bachelorís and masterís degrees in metallurgical physical chemistry from the University of Science and Technology in Beijing, China, in 1986 and 1991, respectively. He received a second masterís degree in physical and analytical chemistry in 1996 from Iowa State University as well as his Ph.D. in chemical engineering in 1999.

Consistently ranked by the National Science Foundation among the top 10 institutions in agricultural research, Virginia Techís College of Agriculture and Life Sciences offers students the opportunity to learn from some of the worldís leading agricultural scientists. The collegeís comprehensive curriculum gives students a balanced education that ranges from food and fiber production to economics to human health. The college is a national leader in incorporating technology, biotechnology, computer applications, and other recent scientific advances into its teaching program.

The College of Engineering at Virginia Tech is internationally recognized for its excellence in 14 engineering disciplines and computer science. The collegeís 5,600 undergraduates benefit from an innovative curriculum that provides a 'hands-on, minds-on' approach to engineering education, complementing classroom instruction with two unique design-and-build facilities and a strong Cooperative Education Program. With more than 50 research centers and numerous laboratories, the college offers its 2,000 graduate students opportunities in advanced fields of study such as biomedical engineering, state-of-the-art microelectronics, and nanotechnology.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   ¬© 2012 NewMaterials.com
Netgains Logo